Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at AED 98.4B, ahead of Eli Lilly (AED 75.8B) and Merck & Co (AED 67B). Figures as of 20 Nov 2026, 06:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonAED 98.4B
- Median
- -AED 175.4M
- Combined market value
- AED 13.72T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | AED 98.4B | AED 2.36T | AED 981.10 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | AED 75.8B | AED 4.42T | AED 4,962.12 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | AED 67B | AED 1.2T | AED 487.76 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | AED 28.5B | AED 576.5B | AED 101.14 | 1.85% down | 15% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | AED 25.9B | AED 438B | AED 214.26 | 2.05% down | 30% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | AED 24B | AED 660.7B | AED 381.47 | 0.58% down | 16% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | AED 16.5B | AED 350.8B | AED 3,391.06 | 2.35% down | 28% up | ||
| 8 | AbbVieABBV · Health Care | AED 15.5B | AED 1.84T | AED 1,041.33 | 0.86% down | 25% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | AED 14.5B | AED 484.8B | AED 1,912.18 | 2.94% down | 27% up | ||
| 10 | ZoetisZTS · Health Care | AED 9.8B | AED 120.6B | AED 296.71 | 5.59% down | 26% down | ||
| 11 | United TherapeuticsUTHR · Health Care | AED 4.9B | AED 87.4B | AED 2,053.35 | 3.16% down | 22% up | ||
| 12 | Royalty PharmaRPRX · Health Care | AED 2.8B | AED 143B | AED 248.71 | 1.38% down | 79% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | AED 2.5B | AED 17.9B | AED 214.20 | 3.16% down | 21% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | AED 1.6B | AED 36B | AED 238.28 | 1.88% down | 117% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | AED 1.3B | AED 43.7B | AED 225.57 | 0.02% down | 17% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | AED 1.2B | AED 72.7B | AED 542.88 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | AED 457.1M | AED 21.1B | AED 1,053.82 | 3.94% down | 50% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | AED 366M | AED 26.1B | AED 238.65 | 4.15% down | 10% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | AED 264.6M | AED 27.4B | AED 78.56 | 2.24% down | 90% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -AED 6M | AED 22.7B | AED 160.31 | 1.25% up | 13% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -AED 85.8M | AED 22.9B | AED 350.77 | 3.27% up | 34% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -AED 93.8M | AED 17B | AED 177.39 | 3.86% down | 45% up | ||
| 23 | VeradermicsMANE · Health Care | -AED 257.1M | AED 19.3B | AED 456.83 | 0.38% down | 231% up | ||
| 24 | Belite BioBLTE · Health Care | -AED 285M | AED 22.5B | AED 554.64 | 3.33% down | 43% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -AED 387.2M | AED 24.3B | AED 358.34 | 1.91% up | 255% up | ||
| 26 | ErascaERAS · Health Care | -AED 457.4M | AED 18.3B | AED 52.22 | 3.34% up | 395% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -AED 478M | AED 29.7B | AED 455.48 | 2.47% down | 51% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -AED 570M | AED 34.1B | AED 358.56 | 3.77% down | 332% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -AED 596.2M | AED 17.5B | AED 311.55 | 1.01% up | 108% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -AED 616.2M | AED 16.6B | AED 151.20 | 0.48% down | 86% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -AED 672.7M | AED 26.2B | AED 498.30 | 1.25% up | 6% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -AED 675M | AED 14.8B | AED 108.27 | 1.24% up | 168% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -AED 721.8M | AED 29.7B | AED 428.96 | 1.88% down | 18% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -AED 852M | AED 48.3B | AED 96.55 | 1.54% down | 26% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -AED 1.1B | AED 33.8B | AED 1,457.07 | 0.34% down | 27% down | ||
| 36 | Legend BiotechLEGN · Health Care | -AED 1.1B | AED 11.5B | AED 59.13 | 0.92% down | 41% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -AED 1.1B | AED 31.9B | AED 1,141.81 | 1.87% up | 86% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -AED 1.2B | AED 17.7B | AED 101.88 | 0.25% down | 20% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -AED 1.4B | AED 16.6B | AED 99.97 | 0.62% down | 63% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -AED 2.7B | AED 55.9B | AED 287.12 | 0.22% up | 21% up | ||
| 41 | CytokineticsCYTK · Health Care | -AED 2.9B | AED 26.3B | AED 188.99 | 0.27% up | 19% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -AED 4B | AED 31B | AED 38.82 | 0.67% up | 36% down | ||
| 43 | InsmedINSM · Health Care | -AED 4.7B | AED 116.4B | AED 530.54 | 20.58% up | 40% down | ||
| 44 | ViatrisVTRS · Health Care | -AED 12.9B | AED 83.7B | AED 73.01 | 1.97% down | 99% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (AED 98.4B), Eli Lilly (AED 75.8B) and Merck & Co (AED 67B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 06:27 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of AED 13.72T as of 20 Nov 2026, 06:27 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.